Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An One Arm, Open and Prospective Studyof Apatinib for the Treatment of Recurrent or Recurrent High-grade Glioma

NCT03390062 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT03390062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An One Arm, Open and Prospective Studyof Apatinib for the Treatment of Recurrent or Recurrent High-grade Glioma
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 4, 2018
Completion date
August 1, 2020
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioma